TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33053456

Group type: EXPERIMENTAL
Intervention: Gluten ingestion (0.5 or 2 g/d for 7 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (for a total of 4 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Baseline symptoms in NCGS patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Stool and urine GIPs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adherence to gluten-free diet (GFD)
Number of subjects: 30
Study: 33074291

Group type: EXPERIMENTAL
Intervention: High-dose erythropoietin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36044664

Group type: EXPERIMENTAL
Intervention: 22-week family-based lifestyle and psychoeducational intervention plus supervised exercise (exercise group, n = 59)
Number of subjects: 116

Group type: COMPARATOR
Intervention: 22-week family-based lifestyle and psychoeducational intervention (control group, n = 57)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Between-group analysis of IMAAT responders
Number of subjects: 116
Study: 33444158

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group
Number of subjects: 3232

Group type: COMPARATOR
Intervention: Metformin group
Number of subjects: 3232

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 3232
Study: 32981043

Group type: EXPERIMENTAL
Intervention: GONB with bupivacaine 0.5% (3 mL each side)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg IV
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: GONB with bupivacaine
Number of subjects: 99

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 99
Study: 35345656

Group type: EXPERIMENTAL
Intervention: BCAA supplementation in the intervention group (Ig)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study: 33619910

Group type: EXPERIMENTAL
Intervention: Antenatal behavioral lifestyle intervention
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 217
Study: 34180437

Group type: EXPERIMENTAL
Intervention: EMG-controlled FES system
Number of subjects: 29
Study: 33871817

Group type: EXPERIMENTAL
Intervention: Givosiran (Givlaari)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36357806

Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate (DMPA‐IM)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Copper intrauterine device (Cu‐IUD)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 458

Group type: COMPARATOR
Intervention: DMPA‐IM
Number of subjects: 458
Study: 33942167

Group type: EXPERIMENTAL
Intervention: NIPEC (Normothermic Intraperitoneal Chemotherapy)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standardized cytoreductive surgery and perioperative chemotherapy
Number of subjects: 74
Study: 32690749

Group type: EXPERIMENTAL
Intervention: Radial 7 French access with Terumo Glidesheath Slender (Terumo, Japan)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Femoral 7 French access
Number of subjects: 388
Study: 36106560

Group type: EXPERIMENTAL
Intervention: Self-distancing writing task
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Self-immersive writing task
Number of subjects: 859

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 859
Study: 33608139

Group type: COMPARATOR
Intervention: CAD + 0.2% NaF (CAD/NaF)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: CAD + CPP-ACP (CAD/ACP)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: CAD + Curodont™ Repair (CAD/P11-4)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Sound dentin (SD)
Number of subjects: 255

Group type: COMPARATOR
Intervention: CAD (Control)
Number of subjects: 255
Study: 32377180

Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture at ST 38 on the nonpainful side
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ipsilateral acupuncture at ST 38 on the painful side
Number of subjects: 24
Study: 36348313

Group type: EXPERIMENTAL
Intervention: Behavioral therapy counseling (8 systematic desensitization sessions, 2-3 sessions per week)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Behavioral therapy counseling
Number of subjects: 46
Study: 33110070

Group type: EXPERIMENTAL
Intervention: COVID-19 outbreak in Wuhan
Number of subjects: 0
Study: 34494903

Group type: EXPERIMENTAL
Intervention: Primary balloon angioplasty
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hydrostatic dilatation
Number of subjects: 80
Study: 33865577

Group type: EXPERIMENTAL
Intervention: Moderate rate of MR (MOD; 0.66 kg/d for 39 d, then 0.33 kg/d for 3 d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ad libitum rate of MR (ADLIB; offered twice daily for 35 d, 0.66 kg/d for 4 d, and 0.33 kg/d for 3 d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Step-up rate of MR (STEPUP; increased from 0.32 to 0.62 kg/d in first 12 d, 0.66 kg/d for 27 d, and 0.33 kg/d for 3 d)
Number of subjects: 48
Study: 33831935

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg orally 24-48 hours before misoprostol)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Misoprostol (400 micrograms every 6 hours vaginally for women at 24 weeks of gestation or less, and 200 micrograms every 4 hours vaginally for women at 24 weeks of gestation or more)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Misoprostol (control)
Number of subjects: 66
Study: 35705934

Group type: EXPERIMENTAL
Intervention: Engagement with healthcare providers (HCPs)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Internalized stigma
Number of subjects: 41
Study: 33968867

Group type: EXPERIMENTAL
Intervention: Psychoeducation group training based on problem-solving skills (4 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 32591326

Group type: EXPERIMENTAL
Intervention: TGA-guided training for pharmacists (three sessions over one year)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Pharmaceutical training program without a communication component
Number of subjects: 640
Study: 32572446

Group type: EXPERIMENTAL
Intervention: Enhanced skin hygiene intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Disposable N95 mask or half facepiece mask with P100 organic vapour cartridge
Number of subjects: 86

Group type: COMPARATOR
Intervention: Normal skin hygiene
Number of subjects: 86
Study: 35552673

Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg orally/day; 3/1 week schedule) and Fulvestrant (500 mg intramuscularly)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Placebo and Fulvestrant (500 mg intramuscularly)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Palbociclib plus Fulvestrant
Number of subjects: 521

Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 521
Study: 32370635

Group type: EXPERIMENTAL
Intervention: Reflecting on important life lessons
Number of subjects: 202

Group type: COMPARATOR
Intervention: Typical morning routine (Control)
Number of subjects: 202
Study: 32248591

Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation (400 IU/d)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 35174850

Group type: EXPERIMENTAL
Intervention: Prophylactic Therapy in Care Homes Trial (PROTECT-CH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33189562

Group type: EXPERIMENTAL
Intervention: Continuation of CDK4/6 inhibitors (CDK4/6i) beyond first disease progression (PD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CDK4/6 inhibitors (CDK4/6i)
Number of subjects: 30
Study: 32271268

Group type: EXPERIMENTAL
Intervention: Phacoemulsification in patients with cornea guttata
Number of subjects: 276362

Group type: COMPARATOR
Intervention: Phacoemulsification in patients without cornea guttata
Number of subjects: 276362
Study: 35807960

Group type: EXPERIMENTAL
Intervention: Theory-Informed Documentary
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study: 34180435

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Etch-and-rinse adhesive system
Number of subjects: 60
Study: 35560470

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplements (140 ml of beetroot juice; 800 mg nitrate/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (140 ml of nitrate-depleted BRJ daily)
Number of subjects: 14
Study: 34114199

Group type: EXPERIMENTAL
Intervention: One-incision procedure (Group A)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Two-incision procedure (Group B)
Number of subjects: 280
Study: 32702276

Group type: EXPERIMENTAL
Intervention: Elastic tape (ET)
Number of subjects: 0
Study: 36177369

Group type: EXPERIMENTAL
Intervention: NMES device (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study: 32070797

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 36293365

Group type: EXPERIMENTAL
Intervention: Combination of Betula alba and Empetrum nigrum extracts
Number of subjects: 0
Study: 33792252

Group type: EXPERIMENTAL
Intervention: Health technology interventions for Heart Failure management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-trial service improvement studies like OPTIMIZE-HF
Number of subjects: 0
Study: 34591080

Group type: EXPERIMENTAL
Intervention: GAIN (geriatric assessment-driven intervention)
Number of subjects: 613

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 613
Study: 36394498

Group type: EXPERIMENTAL
Intervention: Acceptance-Based Therapy (ABT) intervention, 15 virtual, 90-minute group sessions.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Enhanced care, 15 healthy lifestyle handouts, met virtually twice with a registered dietitian.
Number of subjects: 40
Study: 33689702

Group type: EXPERIMENTAL
Intervention: CDK4/6 inhibitors (specific inhibitors not mentioned)
Number of subjects: 0
Study: 32951763

Group type: EXPERIMENTAL
Intervention: Bitter melon extract for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 36065041

Group type: EXPERIMENTAL
Intervention: 6-week reactive agility training program using light-based stimuli (Witty SEM light stimulus), 60-min training sessions twice a week
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study: 33676384

Group type: EXPERIMENTAL
Intervention: Midazolam 2 mg i.v. followed by standard general anesthesia with propofol, oxygen, nitrous oxide 60 %, isoflurane 1 MAC, and sufentanil 5-10 µg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: End of surgery and end of anesthesia with closed eyes
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Post-anesthesia (eyes opened)
Number of subjects: 27
Study: 35289295

Group type: EXPERIMENTAL
Intervention: Amoxicillin 50 mg/kg/d for 7 days
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study: 33727035

Group type: EXPERIMENTAL
Intervention: Post-ARDS psychosocial impairment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-ARDS physical impairment with low psychosocial impairment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-ARDS physical impairment with high psychosocial impairment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-ARDS pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-ARDS fatigue
Number of subjects: 0
Study: 34009881

Group type: EXPERIMENTAL
Intervention: Elbow-Lock Chest Compression (ELCC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard Chest Compression (SCC)
Number of subjects: 34
Study: 34596303

Group type: EXPERIMENTAL
Intervention: Ribbond+FBR
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ribbond+SDR+Filtek Z550
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Filtek Z550
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: FBR
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SDR+Filtek Z550
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: EverX+Filtek Z550
Number of subjects: 120

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 120

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 120
Study: 32543164

Group type: EXPERIMENTAL
Intervention: LINCOCIN®
Number of subjects: 24

Group type: COMPARATOR
Intervention: AZITRO®
Number of subjects: 24
Study: 35072922

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antihypertensive therapy
Number of subjects: 0
Study: 33355637

Group type: EXPERIMENTAL
Intervention: DSAEK with donor cornea preservation time of 7 days or less
Number of subjects: 1090
Study: 35303509

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) delivered by the CyberKnife® system targeting resection margin one month after surgery; total dose of 35 Gy.
Number of subjects: 76

Group type: COMPARATOR
Intervention: Surgery alone (SA) group; no specific dosage mentioned.
Number of subjects: 76
Study: 33990652

Group type: EXPERIMENTAL
Intervention: ABP501
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SB5
Number of subjects: 80

Group type: COMPARATOR
Intervention: ADA originator
Number of subjects: 80
Study: 32653339

Group type: EXPERIMENTAL
Intervention: Proposed bio‐inspired cryptographic DNA system using Whale Optimization Algorithm (WOA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional cryptographic techniques
Number of subjects: 0
Study: 616374539

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35606172

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2364

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 2364
Study: 33161904

Group type: EXPERIMENTAL
Intervention: Blackcurrant purée with added sugars (BC)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Product consisting of blackcurrant purée and fermented quinoa (BCP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference product (SW)
Number of subjects: 26
Study: 33047417

Group type: EXPERIMENTAL
Intervention: Copayment elimination for cardioprotective medications
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tailored self-management support programme
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both interventions (copayment elimination and tailored self-management support)
Number of subjects: 53
Study: 34529944

Group type: EXPERIMENTAL
Intervention: Intensive monitoring
Number of subjects: 2708

Group type: COMPARATOR
Intervention: Limited monitoring
Number of subjects: 2708
Study: 32146337

Group type: EXPERIMENTAL
Intervention: Computerized single-session interventions (SSIs) based on behavioral activation, gratitude, and growth mindset exercises
Number of subjects: 0
Study: 35263746

Group type: EXPERIMENTAL
Intervention: EMiC®2‐CVVHD
Number of subjects: 20

Group type: COMPARATOR
Intervention: AV1000S®‐CVVHDF
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both modalities
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EMiC®2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study: 36224090

Group type: EXPERIMENTAL
Intervention: Brief Motivational Interviewing (BMI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional Oral Hygiene Instruction (OHI)
Number of subjects: 60
Study: 34090360

Group type: EXPERIMENTAL
Intervention: RBF4MNH intervention sites
Number of subjects: 2772

Group type: COMPARATOR
Intervention: Non-RBF intervention sites
Number of subjects: 2772
Study: 32407514

Group type: EXPERIMENTAL
Intervention: Genetically predicted higher glucagon
Number of subjects: 24
Study: 35980127

Group type: EXPERIMENTAL
Intervention: Saddlepoint approximation method for log-rank tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Log-rank tests for clustered data
Number of subjects: 0
Study: 34774196

Group type: EXPERIMENTAL
Intervention: BBV152 vaccine (two intramuscular doses administered 4 weeks apart)
Number of subjects: 25798

Group type: COMPARATOR
Intervention: Placebo (two doses administered 4 weeks apart)
Number of subjects: 25798

Group type: EXPERIMENTAL
Intervention: BBV152 vaccine
Number of subjects: 25798

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25798
Study: 35511655

Group type: EXPERIMENTAL
Intervention: Lenoid™ topical treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34967338

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Endosequence BC RRM putty
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Geristore
Number of subjects: 120

Group type: COMPARATOR
Intervention: Without root-end filling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intact, sound teeth
Number of subjects: 120
Study: 34262151

Group type: EXPERIMENTAL
Intervention: Strength or balance exercise during chemotherapy treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32851644

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 946

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 946

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 946
Study: 33707177

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Interferon-β (IFN-β)
Number of subjects: 207
Study: 35078841

Group type: EXPERIMENTAL
Intervention: Topical airway anaesthesia combined with intravenous induction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Conventional intravenous induction without topical anaesthesia)
Number of subjects: 96
Study: 33629384

Group type: EXPERIMENTAL
Intervention: High-dose intravenous zinc (HDIVZn)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32519032

Group type: EXPERIMENTAL
Intervention: Liquid 6MP formulation (20 mg/ml)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 6MP tablet (50 mg)
Number of subjects: 16
Study: 36200875

Group type: EXPERIMENTAL
Intervention: MRI scoring system for lower-extremity joint and entheseal inflammation
Number of subjects: 56
Study: 33625821

Group type: EXPERIMENTAL
Intervention: Macintosh
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ILMA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: McGrath
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Macintosh and McGrath
Number of subjects: 90
Study: 36209132

Group type: EXPERIMENTAL
Intervention: Low-calorie meal replacement shake (200 kcal) as dinner
Number of subjects: 44

Group type: COMPARATOR
Intervention: Habitual diets (Control)
Number of subjects: 44
Study: 32835607

Group type: EXPERIMENTAL
Intervention: EM-β-carotene (emulsion dispersion formulation)
Number of subjects: 2

Group type: COMPARATOR
Intervention: CR-β-carotene (crystal dispersion formulation)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: EM-β-carotene
Number of subjects: 2

Group type: COMPARATOR
Intervention: CR-β-carotene
Number of subjects: 2
Study: 35041766

Group type: EXPERIMENTAL
Intervention: Compassion-based self-help
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Mindfulness-based self-help
Number of subjects: 130
Study: 34496632

Group type: EXPERIMENTAL
Intervention: Invasive management strategy
Number of subjects: 5179

Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 5179

Group type: EXPERIMENTAL
Intervention: Moderate ischemia
Number of subjects: 5179

Group type: EXPERIMENTAL
Intervention: Severe ischemia
Number of subjects: 5179

Group type: EXPERIMENTAL
Intervention: Increasing CAD severity
Number of subjects: 5179

Group type: EXPERIMENTAL
Intervention: Ischemia severity
Number of subjects: 5179
Study: 33283600

Group type: EXPERIMENTAL
Intervention: Global FFR tertiles (low, mid, high)
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Increase in global FFR by 0.1 unit
Number of subjects: 1122
Study: 35105593

Group type: EXPERIMENTAL
Intervention: Teleophthalmology referral pathway
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AI decision support system (DSS)
Number of subjects: 24
Study: 33773775

Group type: EXPERIMENTAL
Intervention: Moderate feeding rate (454 g for 42 d, and 227 g for 7 d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: High feeding rate (454 g for 7 d, 681 g for 35 d, and 341 g for 7 d)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 17% fat content in milk replacer
Number of subjects: 100

Group type: COMPARATOR
Intervention: 24% fat content in milk replacer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Moderate feeding rate (MOD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: High feeding rate (HI)
Number of subjects: 100
Study: 36260325

Group type: EXPERIMENTAL
Intervention: hsTnT increase of 7 ng/L or more
Number of subjects: 6035

Group type: EXPERIMENTAL
Intervention: hsTnT decrease of 7 ng/L or more
Number of subjects: 6035

Group type: COMPARATOR
Intervention: Stable hsTnT values (change <3 ng/L)
Number of subjects: 6035
Study: 33484628

Group type: EXPERIMENTAL
Intervention: HERB system + standard lifestyle modification
Number of subjects: 146

Group type: COMPARATOR
Intervention: standard lifestyle modification alone
Number of subjects: 146
Study: 35859489

Group type: EXPERIMENTAL
Intervention: Online lecture with PowerPoint presentation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Online short film with discussion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Self-learning online booklet
Number of subjects: 45
Study: 34232452

Group type: EXPERIMENTAL
Intervention: HPV specific intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: General health intervention
Number of subjects: 180
Study: 33888102

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted circulating tHcy levels
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted folate levels
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted vitamin B6 levels
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted vitamin B12 levels
Number of subjects: 14
Study: 32306762

Group type: EXPERIMENTAL
Intervention: Supportive educational intervention (one-month program with three months follow-up, total four months)
Number of subjects: 120